These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 38608418)

  • 21. Clinical and cost-effectiveness of contingency management for cannabis use in early psychosis: the CIRCLE randomised clinical trial.
    Sheridan Rains L; Marston L; Hinton M; Marwaha S; Craig T; Fowler D; King M; Omar RZ; McCrone P; Spencer J; Taylor J; Colman S; Harder C; Gilbert E; Randhawa A; Labuschagne K; Jones C; Stefanidou T; Christoforou M; Craig M; Strang J; Weaver T; Johnson S
    BMC Med; 2019 Aug; 17(1):161. PubMed ID: 31412884
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Demographic and socioenvironmental predictors of premorbid marijuana use among patients with first-episode psychosis.
    Pauselli L; Birnbaum ML; Vázquez Jaime BP; Paolini E; Kelley ME; Broussard B; Compton MT
    Schizophr Res; 2018 Jul; 197():544-549. PubMed ID: 29397281
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cannabis Use Is Associated With Increased Psychotic Symptoms and Poorer Psychosocial Functioning in First-Episode Psychosis: A Report From the UK National EDEN Study.
    Seddon JL; Birchwood M; Copello A; Everard L; Jones PB; Fowler D; Amos T; Freemantle N; Sharma V; Marshall M; Singh SP
    Schizophr Bull; 2016 May; 42(3):619-25. PubMed ID: 26536902
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Impact of comprehensive treatment for first episode psychosis on substance use outcomes: A randomized controlled trial.
    Cather C; Brunette MF; Mueser KT; Babbin SF; Rosenheck R; Correll CU; Kalos-Meyer P
    Psychiatry Res; 2018 Oct; 268():303-311. PubMed ID: 30086471
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prospective study of cannabis use in adolescents at clinical high risk for psychosis: impact on conversion to psychosis and functional outcome.
    Auther AM; McLaughlin D; Carrión RE; Nagachandran P; Correll CU; Cornblatt BA
    Psychol Med; 2012 Dec; 42(12):2485-97. PubMed ID: 22716931
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Course of cannabis use and clinical outcome in patients with non-affective psychosis: a 3-year follow-up study.
    van der Meer FJ; Velthorst E;
    Psychol Med; 2015 Jul; 45(9):1977-88. PubMed ID: 25654244
    [TBL] [Abstract][Full Text] [Related]  

  • 27. An Intersectional Approach to Ethnoracial Disparities in Pathways to Care Among Individuals With Psychosis in Coordinated Specialty Care.
    van der Ven E; Jones N; Bareis N; Scodes JM; Dambreville R; Ngo H; Mathai CM; Bello I; Martínez-Alés G; Mascayano F; Lee RJ; Veling W; Anglin DM; Lewis-Fernandez R; Susser ES; Compton MT; Dixon LB; Wall MM
    JAMA Psychiatry; 2022 Aug; 79(8):790-798. PubMed ID: 35767311
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cannabis consumption and non-alcoholic fatty liver disease. A three years longitudinal study in first episode non-affective psychosis patients.
    Vázquez-Bourgon J; Ortiz-García de la Foz V; Suarez-Pereira I; Iruzubieta P; Arias-Loste MT; Setién-Suero E; Ayesa-Arriola R; Gómez-Revuelta M; Crespo J; Crespo Facorro B
    Prog Neuropsychopharmacol Biol Psychiatry; 2019 Dec; 95():109677. PubMed ID: 31228640
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Schizophrenia and the Environment: Within-Person Analyses May be Required to Yield Evidence of Unconfounded and Causal Association-The Example of Cannabis and Psychosis.
    van Os J; Pries LK; Ten Have M; de Graaf R; van Dorsselaer S; Bak M; Wittchen HU; Rutten BPF; Guloksuz S
    Schizophr Bull; 2021 Apr; 47(3):594-603. PubMed ID: 33693921
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The History of Coordinated Specialty Care for Early Intervention in Psychosis in the United States: A Review of Effectiveness, Implementation, and Fidelity.
    Read H; Kohrt BA
    Community Ment Health J; 2022 Jul; 58(5):835-846. PubMed ID: 34519947
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Impact of comorbid cannabis use on outcome in first episode psychosis.
    Hadden KL; LeDrew K; Hogan K; Thomas B
    Early Interv Psychiatry; 2018 Oct; 12(5):848-855. PubMed ID: 27592556
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cannabis use and symptom severity in individuals at ultra high risk for psychosis: a meta-analysis.
    Carney R; Cotter J; Firth J; Bradshaw T; Yung AR
    Acta Psychiatr Scand; 2017 Jul; 136(1):5-15. PubMed ID: 28168698
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Perceptions of U.S. and Canadian Cannabis Package Warnings Among U.S. Adults.
    Pepper JK; Lee YO; Eggers ME; Allen JA; Thompson J; Nonnemaker JM
    Drug Alcohol Depend; 2020 Dec; 217():108275. PubMed ID: 32971388
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Psychosocial Interventions in Reducing Cannabis Use in Early Phase Psychosis: A Canadian Survey of Treatments Offered.
    Aydin C; Tibbo PG; Ursuliak Z
    Can J Psychiatry; 2016 Jun; 61(6):367-72. PubMed ID: 27254846
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Stopping cannabis use benefits outcome in psychosis: findings from 10-year follow-up study in the PAFIP-cohort.
    Setién-Suero E; Neergaard K; Ortiz-García de la Foz V; Suárez-Pinilla P; Martínez-García O; Crespo-Facorro B; Ayesa-Arriola R
    Acta Psychiatr Scand; 2019 Oct; 140(4):349-359. PubMed ID: 31381129
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Determinants of pathways to care among young adults with early psychosis entering a coordinated specialty care program.
    Marino L; Scodes J; Ngo H; Nossel I; Bello I; Wall M; Dixon L
    Early Interv Psychiatry; 2020 Oct; 14(5):544-552. PubMed ID: 31502409
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Adapting coordinated specialty care in the post-COVID-19 era: study protocol for an integrative mixed-methods study.
    Patel SR; Bello I; Cabassa LJ; Nossel IR; Wall MM; Montague E; Rahim R; Mathai CM; Dixon LB
    Implement Sci Commun; 2021 Jul; 2(1):72. PubMed ID: 34225817
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Relationship between cannabis and psychosis: Reasons for use and associated clinical variables.
    Mané A; Fernández-Expósito M; Bergé D; Gómez-Pérez L; Sabaté A; Toll A; Diaz L; Diez-Aja C; Perez V
    Psychiatry Res; 2015 Sep; 229(1-2):70-4. PubMed ID: 26235479
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Differences in associations between cannabis and stimulant disorders in first admission psychosis.
    Sara G; Burgess P; Malhi GS; Whiteford H; Hall W
    Schizophr Res; 2013 Jul; 147(2-3):216-22. PubMed ID: 23684162
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Alcohol confounds relationship between cannabis misuse and psychosis conversion in a high-risk sample.
    Auther AM; Cadenhead KS; Carrión RE; Addington J; Bearden CE; Cannon TD; McGlashan TH; Perkins DO; Seidman L; Tsuang M; Walker EF; Woods SW; Cornblatt BA
    Acta Psychiatr Scand; 2015 Jul; 132(1):60-8. PubMed ID: 25572323
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.